When and when not to use testosterone for palliation in cancer care (Q38186655)

30 August 2017

title

When and when not to use testosterone for palliation in cancer care (English)

1 reference

30 August 2017

1 reference

1 reference

Eduardo Bruera

1 reference

30 August 2017

Rony Dev

1 reference

30 August 2017

Egidio Del Fabbro

series ordinal

1 reference

30 August 2017

publication date

1 April 2014

1 reference

30 August 2017

published in

Current Oncology Reports

1 reference

30 August 2017

1 reference

30 August 2017

1 reference

30 August 2017

page(s)

378

1 reference

The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Prevalence of symptomatic androgen deficiency in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Hypogonadism in male patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Male hypogonadism associated with advanced cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Transient hypogonadotropic hypogonadism caused by critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Genetic and environmental influences of daily and intra-individual variation in testosterone levels in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

The heritability of circulating testosterone, oestradiol, oestrone and sex hormone binding globulin concentrations in men: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Diagnosis and treatment of hypogonadism in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Chronic pain therapy and hypothalamic-pituitary-adrenal axis impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Endogenous Opioid Regulation of Gonadotropin-Releasing Hormone Release from the Human Fetal Hypothalamusin Vitro*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Endorphins in male impotence: evidence for naltrexone stimulation of erectile activity in patient therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testicular function following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Sexual dysfunction in men and women with endocrine disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Gonadal steroids and body composition, strength, and sexual function in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Mechanisms of action of testosterone--unraveling a Gordian knot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Adverse events associated with testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Female androgen deficiency syndrome--an unproven hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone therapy in women: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Androgen therapy in women: an Endocrine Society Clinical Practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Are the Endocrine Society's Clinical Practice Guidelines on Androgen Therapy in Women misguided? A commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone for low libido in postmenopausal women not taking estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Cancer cachexia and anabolic interventions: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone therapy in men with prostate cancer: scientific and ethical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone replacement therapy after primary treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-014-0378-0

Liver damage from long-term methyltestosterone

21 January 2018

1 reference

12 December 2020

A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms

1 reference

12 December 2020

Testosterone replacement increases fat-free mass and muscle size in hypogonadal men.

1 reference

12 December 2020

Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship

1 reference

12 December 2020

The association between anemia and fatigue in patients with advanced cancer receiving palliative care

1 reference

12 December 2020

Hypogonadism in male patients with metastatic cancer prior to chemotherapy

1 reference

12 December 2020

Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy

1 reference

12 December 2020

Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men

1 reference

12 December 2020

Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer

1 reference

12 December 2020

Early Response Time in Sexual Activity and Mood Following Testosterone Gel Replacement in Hypogonadal Males from the Testim(R) START Study

1 reference

12 December 2020

Loss of circadian rhythmicity in blood testosterone levels with aging in normal men

1 reference

12 December 2020

Testosterone topical solution (Axiron) for hypogonadism

1 reference

12 December 2020

10.1007/S11912-014-0378-0

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1000636157

0 references

1 reference